Concepedia

W.K. Alfred Yung

WA

Statistics

Publications

83

Citations

8.9K

H-Index

46

Active since

1984

Affiliations

The University of Texas MD Anderson Cancer Center(Current)

University of California, San Francisco

Dana-Farber Cancer Institute

Memorial Sloan Kettering Cancer Center

University of California, Los Angeles

W.K. Alfred Yung is an author at The University of Texas MD Anderson Cancer Center specializing in oncology, medicine, and glioblastoma.

ORCID

Publications per year

1984–2025

83

Publications

83

A phase II study of temozolomide vs. procarbazine in patients with glioblastoma multiforme at first relapse

W.K. Alfred Yung, Robert E. Albright, Jeffrey J. Olson et al. · British Journal of Cancer · 2000 · 939 citations · Full text

, , +17

Outcomes and Prognostic Factors in Recurrent Glioma Patients Enrolled Onto Phase II Clinical Trials

Eric T. Wong, Kenneth R. Hess, Mary Jo Gleason et al. · Journal of Clinical Oncology · 1999 · 901 citations

, , +17

Multicenter Phase II Trial of Temozolomide in Patients With Anaplastic Astrocytoma or Anaplastic Oligoastrocytoma at First Relapse

W.K. Alfred Yung, Michael D. Prados, Ricardo Yayá et al. · Journal of Clinical Oncology · 1999 · 763 citations

, , +17

Phase I/II Study of Imatinib Mesylate for Recurrent Malignant Gliomas: North American Brain Tumor Consortium Study 99-08

Patrick Y. Wen, W.K. Alfred Yung, Kathleen R. Lamborn et al. · Clinical Cancer Research · 2006 · 432 citations

, , +16

Phase II Trial of the Antiangiogenic Agent Thalidomide in Patients With Recurrent High-Grade Gliomas

Howard A. Fine, William D. Figg, Kurt A. Jaeckle et al. · Journal of Clinical Oncology · 2000 · 426 citations

, , +15

1–5 of 83